Welcome to neditol.co.uk

Neditol XL^® is a prolonged-release capsule of tolterodine tartrate indicated in symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.¹

Available as:

Neditol XL is bioequivalent to Detrusitol^® (tolterodine) XL (Pfizer Limited, Surrey, UK).²

Neditol XL could offer significant savings to your practice and clinical commissioning group (CCG).

The NHS could make 50% savings on the cost of category C tolterodine by prescribing Neditol XL by brand name.^3*

Quite simply a wholesale switch of tolterodine 2mg and 4mg prolonged-release prolonged-release prescriptions to Neditol XL could still save an average CCG £11,880 per year.^4**

Neditol XL is one of Aspire Pharma’s cost saving prolonged-release products.

In addition Neditol XL:

*50% saving on the cost of Category C tolterodine prolonged-release capsules in the UK Drug Tariff. **Savings based on market data in reference 4. Savings calculated from 2018/2019 spend for 218 CCGs switching their generic and originator brand 2 and 4mg tolterodine prolonged-release capsule prescriptions to Neditol XL. ***No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2024 PPRS review.
References: 1) Neditol XL SmPCs. 2) Data on file. 1010067149 v 4.0 October 2019. 3) February 2020 UK Drug Tariff. 4) epact data Sept 2018 – Sept 2019 (UK)